Biotech Sector Should Outperform Going Forward

15

Biotech (NASDAQ:IBB) still is nowhere near its all time highs despite the S&P500 breaking out to new highs. Its time for biotech to start playing catch-up. Its 30% decline over the last 12 months has resulted in an excellent opportunity for traders. This sector has led the bull run since 2009. Why should it stop now?

This entry was posted in Trading and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *